Clinical Trials Directory

Trials / Unknown

UnknownNCT03968666

Compliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients

Evaluation of Compliance With Enhanced Recovery After Surgery (ERAS) Protocol in Benign Gynecological Surgical Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Augusta University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The concept of "enhanced recovery" was introduced by European anesthesiologists and surgeons who challenged traditional clinical practices involved in peri-operative care in 1990s. The goal of enhanced recovery programs (ERP) is to maintain normal physiology thereby decreasing complications. It focuses on peri-operative optimization of patient care. It was originally created for open colorectal surgeries but now has shown benefit in various surgical specialities including thoracic surgery, vascular surgery, hepatobiliary as well as gynecological surgery. The successful implementation of structured ERAS program requires an ERAS protocol, audit system and a multidisciplinary team. The investigators will evaluate the effect of compliance with the protocol and outcomes such as length of stay, readmissions, morbidity and mortality.

Detailed description

After approval by the Institutional Review Board, the investigators plan to retrospectively study gynecological patients who underwent ERAS protocol at Augusta University Medical Center between January 2017 and February 2019. This is a retrospective observational study to evaluate the outcomes of patients who had ERAS protocol during their surgery. Demographic and outcome variables will be obtained from the institutional health documentation system. The investigators will collect demographic variables (age, ASA status), morphometric measurements (body mass index), time from enrollment to ERAS protocol, hospitalization length of stay, and readmission rate. The investigators will also record the documentation of the ERAS protocol interventions against the ERAS protocol approved by the institution. The investigators will assess the effect of the degree of compliance on outcome variables.

Conditions

Timeline

Start date
2019-06-01
Primary completion
2022-09-30
Completion
2022-10-31
First posted
2019-05-30
Last updated
2022-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03968666. Inclusion in this directory is not an endorsement.